The Profile of MicroRNA Expression and Potential Role in the Regulation of Drug-Resistant Genes in Doxorubicin and Topotecan Resistant Ovarian Cancer Cell Lines
出版年份 2022 全文链接
标题
The Profile of MicroRNA Expression and Potential Role in the Regulation of Drug-Resistant Genes in Doxorubicin and Topotecan Resistant Ovarian Cancer Cell Lines
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 23, Issue 10, Pages 5846
出版商
MDPI AG
发表日期
2022-05-24
DOI
10.3390/ijms23105846
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- The Profile of MicroRNA Expression and Potential Role in the Regulation of Drug-Resistant Genes in Cisplatin- and Paclitaxel-Resistant Ovarian Cancer Cell Lines
- (2022) Dominika Kazmierczak et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The significance of interferon gamma inducible protein 16 (IFI16) expression in drug resistant ovarian cancer cell lines
- (2022) Justyna Borucka et al. BIOMEDICINE & PHARMACOTHERAPY
- Effect of ALDH1A1 Gene Knockout on Drug Resistance in Paclitaxel and Topotecan Resistant Human Ovarian Cancer Cell Lines in 2D and 3D Model
- (2022) Marta Nowacka et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Integrated analysis of deregulation microRNA expression in head and neck squamous cell carcinoma
- (2021) Cheng-Lin Qi et al. MEDICINE
- The lncRNA XIST/miR‐125b‐2‐3p axis modulates cell proliferation and chemotherapeutic sensitivity via targeting Wee1 in colorectal cancer
- (2021) Zhao‐lei Zeng et al. Cancer Medicine
- LINC00665 Stimulates Breast Cancer Progression via Regulating miR-551b-5p
- (2021) Liqiang Qi et al. Cancer Management and Research
- Piperine Targets Different Drug Resistance Mechanisms in Human Ovarian Cancer Cell Lines Leading to Increased Sensitivity to Cytotoxic Drugs
- (2021) Karolina Wojtowicz et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Pathophysiological roles of myristoylated alanine-rich C-kinase substrate (MARCKS) in hematological malignancies
- (2021) Deepak Narayanan Iyer et al. Biomarker Research
- Long non-coding RNA SDCBP2-AS1 delays the progression of ovarian cancer via microRNA-100-5p-targeted EPDR1
- (2021) Xiu Liu et al. World Journal of Surgical Oncology
- Serum miR-125b levels associated with epithelial ovarian cancer (EOC) development and treatment responses
- (2020) Zhonghua Chen et al. Bioengineered
- miRNA profile in ovarian cancer
- (2020) Soudeh Ghafouri-Fard et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- The Significance of MicroRNAs Expression in Regulation of Extracellular Matrix and Other Drug Resistant Genes in Drug Resistant Ovarian Cancer Cell Lines
- (2020) Dominika Kazmierczak et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Let-7i-5p Regulation of Cell Morphology and Migration Through Distinct Signaling Pathways in Normal and Pathogenic Urethral Fibroblasts
- (2020) Kaile Zhang et al. Frontiers in Bioengineering and Biotechnology
- miR‑379‑5p inhibits cell proliferation and promotes cell apoptosis in non‑small cell lung cancer by targeting β‑arrestin‑1
- (2020) Yonghong Jiang et al. Molecular Medicine Reports
- Dysregulation of lnc-SNHG1 and miR-216b-5p correlate with chemoresistance and indicate poor prognosis of serous epithelial ovarian cancer
- (2020) Mei Li Pei et al. Journal of Ovarian Research
- MicroRNA-383 inhibits doxorubicin resistance in hepatocellular carcinoma by targeting eukaryotic translation initiation factor 5A2
- (2019) Chaoyong Tu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- PTPRK Expression Is Downregulated in Drug Resistant Ovarian Cancer Cell Lines, and Especially in ALDH1A1 Positive CSCs-Like Populations
- (2019) Świerczewska et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- MicroRNA profiling of plasma exosomes from patients with ovarian cancer using high‑throughput sequencing
- (2019) Honghong Zhang et al. Oncology Letters
- The Value of Plasma-Based MicroRNAs as Diagnostic Biomarkers for Ovarian Cancer
- (2019) Weiwei Wang et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- MicroRNA Profiling During Neural Differentiation of Induced Pluripotent Stem Cells
- (2019) Katarzyna Kulcenty et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Micro RNA ‐551b‐3p inhibits tumour growth of human cholangiocarcinoma by targeting Cyclin D1
- (2019) Weiping Chang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Downregulation of miR-216a-5p by long noncoding RNA PVT1 suppresses colorectal cancer progression via modulation of YBX1 expression
- (2019) Xiang Zeng et al. Cancer Management and Research
- MicroRNA-935 acts as a prognostic marker and promotes cell proliferation, migration, and invasion in colorectal cancer
- (2019) Ying Huang et al. Cancer Biomarkers
- Expression of Osteoblast-Specific Factor 2 (OSF-2, Periostin) Is Associated with Drug Resistance in Ovarian Cancer Cell Lines
- (2019) Karolina Sterzyńska et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Circulating miRNA Profiling in Plasma Samples of Ovarian Cancer Patients
- (2019) András Penyige et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Role of MicroRNAs in Early Chondrogenesis of Human Induced Pluripotent Stem Cells (hiPSCs)
- (2019) Ewelina Stelcer et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Identification of gene and microRNA changes in response to smoking in human airway epithelium by bioinformatics analyses
- (2019) Jizhen Huang et al. MEDICINE
- The Impact of Integrin-Mediated Matrix Adhesion on Cisplatin Resistance of W1 Ovarian Cancer Cells
- (2019) Kathleen Wantoch von Rekowski et al. Biomolecules
- MiR-935 Promotes Clear Cell Renal Cell Carcinoma Migration and Invasion by Targeting IREB2
- (2019) Fei Liu et al. Cancer Management and Research
- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- HOTAIR enhanced paclitaxel and doxorubicin resistance in gastric cancer cells partly through inhibiting miR-217 expression
- (2018) Hui Wang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Characterization of the breast cancer resistance protein (BCRP/ABCG2 ) in clear cell renal cell carcinoma
- (2018) Anna Reustle et al. INTERNATIONAL JOURNAL OF CANCER
- Knockdown of miR‑935 increases paclitaxel sensitivity via regulation of SOX7 in non‑small‑cell lung cancer
- (2018) Bing Peng et al. Molecular Medicine Reports
- Paclitaxel resistance and the role of miRNAs in prostate cancer cell lines
- (2018) Hale Samli et al. WORLD JOURNAL OF UROLOGY
- Up-regulation of miR-383-5p suppresses proliferation and enhances chemosensitivity in ovarian cancer cells by targeting TRIM27
- (2018) Jing Jiang et al. BIOMEDICINE & PHARMACOTHERAPY
- Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells
- (2018) Akihiko Yoshimura et al. BMC CANCER
- Updates and current challenges in microRNA research for personalized medicine in ovarian cancer
- (2017) Victoria Mandilaras et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- The crucial role of protein phosphorylation in cell signaling and its use as targeted therapy (Review)
- (2017) Fatima Ardito et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- SpidermiR: An R/Bioconductor Package for Integrative Analysis with miRNA Data
- (2017) Claudia Cava et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- MicroRNA-mediated drug resistance in ovarian cancer
- (2017) Aynaz Mihanfar et al. JOURNAL OF CELLULAR PHYSIOLOGY
- miRNAs and ovarian cancer: An overview
- (2017) Bornali Deb et al. JOURNAL OF CELLULAR PHYSIOLOGY
- New and Old Genes Associated with Primary and Established Responses to Cisplatin and Topotecan Treatment in Ovarian Cancer Cell Lines
- (2017) Monika Świerczewska et al. MOLECULES
- miR-935 Promotes Liver Cancer Cell Proliferation and Migration by Targeting SOX7
- (2017) Xiaorui Liu et al. ONCOLOGY RESEARCH
- MicroRNA 217 inhibits cell proliferation and enhances chemosensitivity to doxorubicin in acute myeloid leukemia by targeting KRAS
- (2017) Yi Xiao et al. Oncology Letters
- FirebrowseR: an R client to the Broad Institute’s Firehose Pipeline
- (2017) Mario Deng et al. Database-The Journal of Biological Databases and Curation
- The significance of lumican expression in ovarian cancer drug-resistant cell lines
- (2017) Andrzej Klejewski et al. Oncotarget
- Microarray-based detection and expression analysis of new genes associated with drug resistance in ovarian cancer cell lines
- (2017) Radosław Januchowski et al. Oncotarget
- MicroRNA-218 inhibits proliferation and invasion in ovarian cancer by targeting Runx2
- (2017) Na Li et al. Oncotarget
- MicroRNA-212/ABCG2-axis contributes to development of imatinib-resistance in leukemic cells
- (2017) Meike Kaehler et al. Oncotarget
- ABC transporters as mediators of drug resistance and contributors to cancer cell biology
- (2016) Jamie I. Fletcher et al. DRUG RESISTANCE UPDATES
- Roles of eukaryotic topoisomerases in transcription, replication and genomic stability
- (2016) Yves Pommier et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Analysis of MDR genes expression and cross-resistance in eight drug resistant ovarian cancer cell lines
- (2016) Radosław Januchowski et al. Journal of Ovarian Research
- Increased Expression of Several Collagen Genes is Associated with Drug Resistance in Ovarian Cancer Cell Lines
- (2016) Radosław Januchowski et al. Journal of Cancer
- An overview of microRNAs
- (2015) Scott M. Hammond ADVANCED DRUG DELIVERY REVIEWS
- Receptor-type tyrosine-protein phosphatase directly targets STAT3 activation for tumor suppression in nasal NK/T-cell lymphoma
- (2015) Y.-W. Chen et al. BLOOD
- MicroRNA Let-7i Negatively Regulates Cardiac Inflammation and FibrosisNovelty and Significance
- (2015) Xia Wang et al. HYPERTENSION
- limma powers differential expression analyses for RNA-sequencing and microarray studies
- (2015) Matthew E. Ritchie et al. NUCLEIC ACIDS RESEARCH
- Tumor suppressor role of miR-217 in human epithelial ovarian cancer by targeting IGF1R
- (2015) JIEYAN LI et al. ONCOLOGY REPORTS
- Unveiling the principle of microRNA-mediated redundancy in cellular pathway regulation
- (2015) Simon Fischer et al. RNA Biology
- Identification and characterization of tumor suppressor and oncogenic miRNAs in gastric cancer
- (2015) ZHAOFENG CHEN et al. Oncology Letters
- Elevated MARCKS phosphorylation contributes to unresponsiveness of breast cancer to paclitaxel treatment
- (2015) Ching-Hsien Chen et al. Oncotarget
- Receptor-type protein tyrosine phosphatases in cancer
- (2015) Yu Du et al. Chinese Journal of Cancer
- Global miRNA expression analysis of serous and clear cell ovarian carcinomas identifies differentially expressed miRNAs including miR-200c-3p as a prognostic marker
- (2014) Bente Vilming Elgaaen et al. BMC CANCER
- Targeting phospho-MARCKS overcomes drug-resistance and induces antitumor activity in preclinical models of multiple myeloma
- (2014) Y Yang et al. LEUKEMIA
- ADAM9 Up-Regulates N-Cadherin via miR-218 Suppression in Lung Adenocarcinoma Cells
- (2014) Yuh-Pyng Sher et al. PLoS One
- Extracellular Matrix Proteins Expression Profiling in Chemoresistant Variants of the A2780 Ovarian Cancer Cell Line
- (2014) Radosław Januchowski et al. Biomed Research International
- Microarray-based detection and expression analysis of ABC and SLC transporters in drug-resistant ovarian cancer cell lines
- (2013) Radosław Januchowski et al. BIOMEDICINE & PHARMACOTHERAPY
- Smaug
- (2013) Benjamin D Pinder et al. FLY
- Protein tyrosine phosphatase kappa (PTPRK) is a negative regulator of adhesion and invasion of breast cancer cells, and associates with poor prognosis of breast cancer
- (2013) Ping-Hui Sun et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- miR-379 Regulates Cyclin B1 Expression and Is Decreased in Breast Cancer
- (2013) Sonja Khan et al. PLoS One
- Downregulation of miRNA-31 induces taxane resistance in ovarian cancer cells through increase of receptor tyrosine kinase MET
- (2013) T Mitamura et al. Oncogenesis
- The tumor microenvironment is a dominant force in multidrug resistance
- (2012) Ana Luísa Correia et al. DRUG RESISTANCE UPDATES
- Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
- (2012) Oktay Tacar et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- MDR Gene Expression Analysis of Six Drug-Resistant Ovarian Cancer Cell Lines
- (2012) Radosław Januchowski et al. Biomed Research International
- Glucocorticoid Regulation of SLIT/ROBO Tumour Suppressor Genes in the Ovarian Surface Epithelium and Ovarian Cancer Cells
- (2011) Rachel E. Dickinson et al. PLoS One
- Topotecan for relapsed small cell lung cancer: A systematic review and economic evaluation
- (2010) Debbie Hartwell et al. CANCER TREATMENT REVIEWS
- DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs
- (2010) Yves Pommier et al. CHEMISTRY & BIOLOGY
- Gene expression analysis of drug-resistant MCF-7 cells: implications for relation to extracellular matrix proteins
- (2009) Özlem Darcansoy Işeri et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Ovarian cancer
- (2009) Bryan T Hennessy et al. LANCET
- MicroRNAs in Cancer
- (2008) Yong Sun Lee et al. Annual Review of Pathology-Mechanisms of Disease
- p21 and p27: roles in carcinogenesis and drug resistance
- (2008) Abde M. Abukhdeir et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Most mammalian mRNAs are conserved targets of microRNAs
- (2008) R. C. Friedman et al. GENOME RESEARCH
- Nonplatinum Topotecan Combinations Versus Topotecan Alone for Recurrent Ovarian Cancer: Results of a Phase III Study of the North-Eastern German Society of Gynecological Oncology Ovarian Cancer Study Group
- (2008) Jalid Sehouli et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Trial of Gemcitabine Compared With Pegylated Liposomal Doxorubicin in Progressive or Recurrent Ovarian Cancer
- (2008) Gabriella Ferrandina et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started